Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline ...

The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...

The 9 recipients receive $55,000 in seed money for collaborative projects that target one or more of the foundation’s ...

The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in ...

The combined companies will operate under the name Kalaris Therapeutics, Inc. and expects to report initial data from part 1 ...

Intraoperative floppy iris syndrome is associated with an increased rate of severe intraoperative complications and greater ...

The bio-interventional platform is for uveoscleral outflow enhancement in open-angle glaucoma patients undergoing combined ...

A retrospective study showed that the gender of the ophthalmologist influenced the amount of communication with the patient, ...

After review by the Data and Safety Monitoring Board, the dosing of OCU200 in patients with diabetic macular edema (DME) will ...

The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed ...

Formosa Pharmaceuticals and Cipla Limited have entered into an exclusive licensing agreement for the commercialization of ...

This program is in place for prescriptions of cyclosporine ophthalmic solution 0.1% (VEVYE, Harrow) and promises a $59 price ...